期刊文献+

儿童免疫性血小板减少症患者外周血B淋巴细胞亚群变化的研究 被引量:3

B Lymphocyte Subsets in Peripheral Blood of Patients with Pediatric Immune Thrombocytopenia
下载PDF
导出
摘要 目的探讨儿童免疫性血小板减少症患者(immune thrombocytopenia,ITP)外周血中CD38,CD27,CD19表达阳性的B淋巴细胞亚群的变化及临床意义。方法选取2017年1月~12月中山大学孙逸仙纪念医院收治的初诊ITP患儿21例为初诊未治疗组(untreated ITP,U-ITP),完全缓解ITP患儿30例为完全缓解组(remission ITP,R-ITP)及同期健康体检儿童26例为健康对照组(normal control,NC),运用流式细胞术对其外周血B淋巴细胞亚群进行检测并与ITP患儿的PLT计数进行相关性分析。结果外周血总CD19^+B淋巴细胞比例:U-ITP组显著高于R-ITP组和NC组(F=7.543,P<0.01)。外周血CD19^+CD27^+CD38-记忆性B细胞占CD19^+B细胞百分率:U-ITP组显著高于R-ITP组和NC组(F=8.876,P<0.001)。CD19^+CD27-CD38-初始B细胞占CD19^+B细胞百分率:U-ITP组显著低于R-ITP组)和NC组(F=5.058,P<0.01)。CD19^+CD27^+CD38^+浆母细胞百分率:U-ITP组显著高于R-ITP组和NC组(F=9.588,P<0.001),而R-ITP组与NC组比较,B淋巴细胞各分群差异均无统计学意义(F=0.842~1.258,均P>0.05)。PLT计数与总CD19^+B细胞百分率呈负相关(r=-0.318,P=0.007),与CD19^+CD27^+CD38-记忆性B细胞百分率呈负相关(r=-0.444,P=0.000),与CD19^+CD27-CD38-初始B细胞百分率呈正相关(r=0.416,P=0.000),与CD19^+CD27^+CD38^+浆母细胞百分率呈负相关(r=-0.442,P=0.000)。结论 B淋巴细胞亚群在ITP患儿体内分布存在异常,其检测能够为ITP患儿临床疾病监测与判断预后提供重要的指导作用。 Objective To investigate the change and clinical significance of B lymphocyte subsets marked by CD38,CD27 and CD19 in peripheral blood of pediatric patients with immune thrombocytopenia. Methods A total of 51 ITP patients(21 patients were newly diagnosed and untreated, 30 patients were in remission)were collected from January 2017 to December 2017 in Sun Yat-Sen Memorial Hospital,and 26 normal controls were enrolled in this study. The abnormal of B lymphocyte subsets in peripheral blood of research cohort were detected by flow cytometry and their correlations with platelet count were analyzed. Results The percentage of total CD19 B cells of untreated ITP patients was significantly higher than that of remission ITP patients and normal controls (F= 7. 543, P〈0.01). The percentage of memory B cells in CD19 B cells of untreated ITP patients was significantly higher than that of remission ITP patients and normal controls (F =8. 876, P〈 0. 001). The percentage of naive B cells in CD19 1B cells of untreated ITP patients was significantly lower than that of remission ITP patients and normal controls (F =5. 058, P〈0.01). The percentage of plasmablasts cells of untreated ITP patients was significantly higher than that of remission ITP patients and normal controls (F= 9. 588, P〈0. 001). There was no significant difference in B lymphocyte subsets between remission ITP patients and the normal controls (F =0. 842- 1. 258, all P〉0.05). The PLT count had significantly negative correlation with the percentage of total CD19 1 B cells (r =0. 318, P = 0. 007), memory B cells (r= 0. 444, P= 0. 000), plasmablasts cells (r= 0. 442, P= 0. 000) and had significantly positive correlation with naive B cells (r=0. 416, P =0. 000). Conclusion The distribution of B lymphocyte subsets was abnormal in ITP patients. The detection of B lymphocyte subsets can be used as a useful indicator of clinical disease surveillance and prognosis in ITP patients.
作者 刘纯岳 方俊粤 林帝金 鲍蕴文 陆晓红 林向华 LIU Chun- yue,FANG Jun -yue,LIN Di -jin,BAO Yun -wen,LU Xiao -hong,LIN Xiang- hua(Department of Clinical Laboratory, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou 510120, China)
出处 《现代检验医学杂志》 CAS 2018年第6期59-62,共4页 Journal of Modern Laboratory Medicine
关键词 免疫性血小板减少症 B淋巴细胞亚群 CD38 CD27 CD19 immunological thrombocytopenia B lymphocyte subsets CD3 8 CD2 7 CD19
  • 相关文献

参考文献1

二级参考文献21

  • 1Yong M, Schoonen WM, Li L, et al. Epidemiology of paediatric immune thrombocytopenia in the General Practice Research Database. Br J Haematol, 2010, 149: 855-864.
  • 2Rosthcj S, Hedlund-Treutiger I, Rajantie J, et al. Duration and morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children : A prospective nordic study of an unselected cohort. J Pediatr, 2003, 143:302-307.
  • 3Kiihne T, Buchanan GR, Zimmetlan S, et al. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the intercontinental childhood ITP study group. J Pediatr, 2003, 143 : 605 -608.
  • 4British Committee for Standards in Hematology General Hematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol. 2003. 120:574-596.
  • 5Geddis AE, Balduini CL. Diagnosis of immune thrombocytopenicpurpura in children. Curr Opin Hematol, 2007,14:520-525.
  • 6Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenie purpura of adults and children: report from an international working group. Blood, 2009, 113:2386-2393.
  • 7Blanehette V, Carcao M. Approach to the investigation and management of immune thrombocytopenie purpura in children. Semin Hematol, 2000,37:299-314.
  • 8Beck CE, Nathan PC, Parkin PC, et al. Corticosteroids versus intravenous immune globulin for the treatment of acute immune thrombocytopenic purpura in children: a systematic review and meta-analysis of randomized controlled trials. J Pediatr, 2005, 147:521-527.
  • 9Gaines AR. Disseminated intravascular coagulation associated with acutehemoglobinemia or hemoglobinuria following Rh (0) (D) immune globulin intravenous administration for immune thrombocytopenic purpura. Blood, 2005,106 : 1532-1537.
  • 10Hedlund-Treutiger I, Henter JI, Elinder G. Randomized study of IVIg and high-dose dexamethasone therapy for children with chronic idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol, 2003, 25:139-144.

共引文献211

同被引文献29

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部